Genetic Risk Factors for Folate-Responsive Neural Tube Defects

Annual Review of Nutrition

Volumn 37, Issue , 2017, Pages 269-291

  Molloy, Anne M ^a   Pangilinan, Faith ^b   Brody, Lawrence C ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Anencephaly; Folic acid; MTHFR; Spina bifida; Vitamin B12

Indexed keywords

FOLIC ACID;

ANIMAL; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; NEURAL TUBE DEFECTS; RISK FACTOR;

ANIMALS; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICE; NEURAL TUBE DEFECTS; RISK FACTORS;

EID: 85028001684     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071714-034235     Document Type: Review

References (153)

1. Afman LA, Van Der Put NM, Thomas CM, Trijbels JM, Blom HJ. 2001. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. Q. J. Med. 94:159-66
2. Amorim MR, Lima MA, Castilla EE, Orioli IM. 2007. Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C T: A meta-analysis. Am. J. Med. Genet. 143A:1726-32
3. Anderson DD, Woeller CF, Stover PJ. 2007. Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase. Clin. Chem. Lab. Med. 45:1760-63
4. Aneji CN, Northrup H, Au KS. 2012. Deep sequencing study of the MTHFR gene to identify variants associated with myelomeningocele. Birth Defects Res. A Clin. Mol. Teratol. 94:84-90
5. Atta CA, Fiest KM, Frolkis AD, Jette N, Pringsheim T, et al. 2016. Global birth prevalence of spina bifida by folic acid fortification status: A systematic review and meta-analysis. Am. J. Public Health 106:e24-34
6. Au KS, Ashley-Koch A, Northrup H. 2010. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev. Disabil. Res. Rev. 16:6-15
7. Bailey SW, Ayling JE. 2009. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. PNAS 106:15424-29
8. Barbera JP, Rodriguez TA, Greene ND, Weninger WJ, Simeone A, et al. 2002. Folic acid prevents exencephaly in Cited2 deficient mice. Hum. Mol. Genet. 11:283-93
9. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinform 21:263-65
10. Bassuk AG, Muthuswamy LB, Boland R, Smith TL, Hulstrand AM, et al. 2013. Copy number variation analysis implicates the cell polarity gene glypican 5 as a human spina bifida candidate gene. Hum. Mol. Genet. 22:1097-111
11. Beaudin AE, Abarinov EV, Noden DM, Perry CA, Chu S, et al. 2011. Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. Am. J. Clin. Nutr. 93:789-98
12. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57:281-300
13. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, et al. 1999. Prevention of neural-tube defects with folic acid in China. N. Engl. J. Med. 341:1485-90
14. Besser LM, Williams LJ, Cragan JD. 2007. Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long-term trends, Atlanta, Georgia, 1968-2003. Birth Defects Res. A Clin. Mol. Teratol. 79:730-36
15. Bhide P, Sagoo GS, Moorthie S, Burton H, Kar A. 2013. Systematic review of birth prevalence of neural tube defects in India. Birth Defects Res. A Clin. Mol. Teratol. 97:437-43
16. Blom HJ, Shaw GM, den Heijer M, Finnell RH. 2006. Neural tube defects and folate: Case far from closed. Nat. Rev. Neurosci. 7:724-31
17. Botto LD, Moore CA, Khoury MJ, Erickson JD. 1999. Neural-tube defects. N. Engl. J.Med. 341:1509-19
18. Botto LD, Yang Q. 2000. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A Hu GE review. Am. J. Epidemiol. 151:862-77
19. Brody LC, Baker PJ, Chines PS, Musick A, Molloy AM, et al. 1999. Methionine synthase: High-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects. Mol. Genet.Metab. 67:324-33
20. Brody LC, Conley M, Cox C, Kirke PN, Mc Keever MP, et al. 2002. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am. J. Hum. Genet. 71:1207-15
21. Brosnan ME, Mac Millan L, Stevens JR, Brosnan JT. 2015. Division of labour: How does folate metabolism partition between one-carbon metabolism and amino acid oxidation Biochem. J. 472:135-46
22. Burgoon JM, Selhub J, Nadeau M, Sadler TW. 2002. Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. Teratology 65:219-27
23. Carter M, Ulrich S, Oofuji Y, Williams DA, Ross ME. 1999. Crooked tail (Cd) models human folateresponsive neural tube defects. Hum. Mol. Genet. 8:2199-204
24. Carter TC, Pangilinan F, Troendle JF, Molloy AM, Vander Meer J, et al. 2011. Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population. Am. J. Med. Genet. 155A:14-21
25. Champion KM, Cook RJ, Tollaksen SL, Giometti CS. 1994. Identification of a heritable deficiency of the folate-dependent enzyme 10-formyltetrahydrofolate dehydrogenase in mice. PNAS 91:11338-42
26. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, et al. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10:433-43
27. Connealy BD, Northrup H, Au KS. 2014. Genetic variations in the GLUT3 gene associated with myelomeningocele. Am. J. Obstet. Gynecol. 211:305.e1-e8
28. Copp AJ, Greene ND. 2010. Genetics and development of neural tube defects. J. Pathol. 220:217-30
29. Copp AJ, Greene ND. 2013. Neural tube defects: Disorders of neurulation and related embryonic processes. Wiley Interdiscip. Rev. Dev. Biol. 2:213-27
30. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1832-35
31. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. 1995. Folate levels and neural tube defects. Implications for prevention. JAMA 274:1698-702
32. De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, et al. 2006. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958GA polymorphism for neural tube defect risk. J. Hum. Genet. 51:98-103
33. Deak KL, Siegel DG, George TM, Gregory S, Ashley-Koch A, Speer MC. 2008. Further evidence for a maternal genetic effect and a sex-influenced effect contributing to risk for human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 82:662-69
34. Di Pietro E, Sirois J, Tremblay ML, Mac Kenzie RE. 2002. Mitochondrial NAD-dependentmethylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is essential for embryonic development. Mol. Cell Biol. 22:4158-66
35. Drainer E, May HM, Tolmie JL. 1991. Do familial neural tube defects breed true J. Med. Genet. 28:605-8
36. Economides DL, Ferguson J, Mackenzie IZ, Darley J, Ware II, Holmes-Siedle M. 1992. Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br. J. Obstet. Gynaecol. 99:23-25
37. Elmore CL, Wu X, Leclerc D, Watson ED, Bottiglieri T, et al. 2007. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol. Genet. Metab. 91:85-97
38. Elwood JM, Elwood JH. 1980. Epidemiology of Anencephalus and Spina Bifida. New York: Oxford Univ. Press
39. Elwood JM, Little J, Elwood JH. 1992. Epidemiology and Control of Neural Tube Defects. Oxford: Oxford Univ. Press
40. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. 1995. Thermolabile 5, 10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am. J. Hum. Genet. 56:142-50
41. Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD. 2014. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510:298-302
42. Field MS, Kamynina E, Agunloye OC, Liebenthal RP, Lamarre SG, et al. 2014. Nuclear enrichment of folate cofactors and methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) protect de novo thymidylate biosynthesis during folate deficiency. J. Biol. Chem. 289:29642-50
43. Fisk Green R, Byrne J, Crider KS, Gallagher M, Koontz D, Berry RJ. 2013. Folate-related gene variants in Irish families affected by neural tube defects. Front. Genet. 4:223
44. Franke B, Vermeulen SH, Steegers-Theunissen RP, Coenen MJ, Schijvenaars MM, et al. 2009. An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and t RNA aspartic acid methyltransferase 1 (TRDMT1). Birth Defects Res. A Clin. Mol. Teratol. 85:216-26
45. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, et al. 2002. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. PNAS 99:5606-11
46. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al. 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:111-13
47. Gao L, Chalupsky K, Stefani E, Cai H. 2009. Mechanistic insights into folic acid-dependent vascular protection: Dihydrofolate reductase-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: A novel HPLC-based fluorescent assay for DHFR activity. J. Mol. Cell Cardiol. 47:752-60
48. Garabedian BH, Fraser FC. 1993. Upper and lower neural tube defects: An alternate hypothesis. J. Med. Genet. 30:849-51
49. Gardiki-Kouidou P, Seller MJ. 1988. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin. Genet. 33:441-48
50. Gelineau-van Waes J, Heller S, Bauer LK, Wilberding J, Maddox JR, et al. 2008. Embryonic development in the reduced folate carrier knockout mouse is modulated by maternal folate supplementation. Birth Defects Res. A Clin. Mol. Teratol. 82:494-507
51. Genomes Proj. Consort. 2015. A global reference for human genetic variation. Nature 526:68-74
52. Gorroochurn P, Hodge SE, Heiman GA, Durner M, Greenberg DA. 2007. Non-replication of association studies: "pseudo-failures" to replicate Genet. Med. 9:325-31
53. Greene ND, Copp AJ. 2014. Neural tube defects. Annu. Rev. Neurosci. 37:221-42
54. Greene ND, Stanier P, Copp AJ. 2009. Genetics of human neural tube defects. Hum. Mol. Genet. 18:R113-29
55. Harris MJ, Juriloff DM. 2007. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 79:187-210
56. Harris MJ, Juriloff DM. 2010. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res. A Clin. Mol. Teratol. 88:653-69
57. Heid MK, Bills ND, Hinrichs SH, Clifford AJ. 1992. Folate deficiency alone does not produce neural tube defects in mice. J. Nutr. 122:888-94
58. Herbig K, Chiang EP, Lee LR, Hills J, Shane B, Stover PJ. 2002. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J. Biol. Chem. 277:38381-89
59. Jakubowski H, Perla-Kajan J, Finnell RH, Cabrera RM, Wang H, et al. 2009. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J. 23:1721-27
60. Jarrett JT, Hoover DM, Ludwig ML, Matthews RG. 1998. The mechanism of adenosylmethioninedependent activation of methionine synthase: A rapid kinetic analysis of intermediates in reductive methylation of Cob(II)alamin enzyme. Biochemistry 37:12649-58
61. Jiang J, Zhang Y, Wei L, Sun Z, Liu Z. 2014. Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: A meta-analysis. PLOS ONE 9:e101169
62. Joo JG, Beke A, Papp Z, Csaba A, Rab A, Papp C. 2007. Risk of recurrence in major central nervous system malformations between 1976 and 2005. Prenat. Diagn. 27:1028-32
63. Källen B, L ofkvist E. 1984. Time trends of spina bifida in Sweden 1947-81. J. Epidemiol. Community Health 38:103-7
64. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. 1991. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am. J. Hum. Genet. 48:536-45
65. Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G. 1988. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 43:414-21
66. Khoshnood B, Loane M, de Walle H, Arriola L, Addor MC, et al. 2015. Long term trends in prevalence of neural tube defects in Europe: Population based study. BMJ 351:h5949
67. Kirke PN, Daly LE, Elwood JH. 1992. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch. Dis. Child 67:1442-46
68. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med. 86:703-8
69. Krupp DR, Soldano KL, Garrett ME, Cope H, Ashley-Koch AE, Gregory SG. 2014. Missing genetic risk in neural tube defects: Can exome sequencing yield an insight Birth Defects Res. A Clin. Mol. Teratol. 100:642-46
70. Lamarre SG, Molloy AM, Reinke SN, Sykes BD, Brosnan ME, Brosnan JT. 2012. Formate can differentiate between hyperhomocysteinemia due to impaired remethylation and impaired transsulfuration. Am. J. Physiol. Endocrinol. Metab. 302:E61-67
71. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. 1981. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 282:1509-11
72. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, et al. 2016. Analysis of protein-coding genetic variation in 60, 706 humans. Nature 536:285-91
73. Lemay P, Guyot MC, Tremblay E, Dionne-Laporte A, Spiegelman D, et al. 2015. Loss-of-function de novo mutations play an important role in severe human neural tube defects. J. Med. Genet. 52:493-97
74. Lencz T, Malhotra AK. 2015. Targeting the schizophrenia genome: A fast track strategy from GWAS to clinic. Mol. Psychiatry 20:820-26
75. Li D, Pickell L, Liu Y, Wu Q, Cohn JS, Rozen R. 2005. Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am. J. Clin. Nutr. 82:188-95
76. Lin W, Zhang Z, Srajer G, Chen YC, Huang M, et al. 2008. Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. Dev. Dyn. 237:928-40
77. Liu J, Qi J, Yu X, Zhu J, Zhang L, et al. 2014. Investigations of single nucleotide polymorphisms in folate pathway genes in Chinese families with neural tube defects. J. Neurol. Sci. 337:61-66
78. Liu J, Zhang Y, Jin L, Li G, Wang L, et al. 2015. Variants in maternal COMT and MTHFR genes and risk of neural tube defects in offspring. Metab. Brain Dis. 30:507-13
79. Ma DW, Finnell RH, Davidson LA, Callaway ES, Spiegelstein O, et al. 2005. Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res. 65:887-97
80. Mac Farlane AJ, Liu X, Perry CA, Flodby P, Allen RH, et al. 2008. Cytoplasmic serine hydroxymethyltransferase regulates themetabolic partitioning of methylenetetrahydrofolate but is not essential in mice. J. Biol. Chem. 283:25846-53
81. Martinez CA, Northrup H, Lin JI, Morrison AC, Fletcher JM, et al. 2009. Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida. Am. J. Obstet. Gynecol. 201:394.e1-11
82. Martiniova L, Field MS, Finkelstein JL, Perry CA, Stover PJ. 2015. Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects. Am. J. Clin. Nutr. 101:860-69
83. Meng J, Han L, Zhuang B. 2015. Association between MTHFD1 polymorphisms and neural tube defect susceptibility. J. Neurol. Sci. 348:188-94
84. Mills JL, Tuomilehto J, Yu KF, Colman N, Blaner WS, et al. 1992. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J. Pediatr. 120:863-71
85. Molloy AM, Brody LC, Mills JL, Scott JM, Kirke PN. 2009. The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 85:285-94
86. Molloy AM, Kirke P, Hillary I, Weir DG, Scott JM. 1985. Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. Arch. Dis. Child. 60:660-65
87. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, et al. 2009. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 123:917-23
88. Momb J, Appling DR. 2014. Mitochondrial one-carbon metabolism and neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 100:576-83
89. Momb J, Lewandowski JP, Bryant JD, Fitch R, Surman DR, et al. 2013. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. PNAS 110:549-54
90. Moore CA, Li S, Li Z, Hong SX, Gu HQ, et al. 1997. Elevated rates of severe neural tube defects in a high-prevalence area in Northern China. Am. J. Med. Genet. 73:113-18
91. MRCVitam. Study Res. Group. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131-37
92. Murphy M, Seagroatt V, Hey K, O'Donnell M, Godden M, et al. 1996. Neural tube defects 1974-94: Down but not out. Arch. Dis. Child. 75:F133-34
93. Narisawa A, Komatsuzaki S, Kikuchi A, Niihori T, Aoki Y, et al. 2012. Mutations in genes encoding the glycine cleavage system predispose to neural tube defects in mice and humans. Hum. Mol. Genet. 21:1496-503
94. O'Leary VB, Mills JL, Parle-Mc Dermott A, Pangilinan F, Molloy AM, et al. 2005. Screening for new MTHFR polymorphisms and NTD risk. Am. J. Med. Genet. 138A:99-106
95. O'Rahilly R, Muller F. 1994. Neurulation in the normal human embryo. Ciba Found. Symp. 181:70-82
96. O'Rahilly R, Muller F. 2002. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology 65:162-70
97. Ouyang S, Li Y, Liu Z, Chang H, Wu J. 2013. Association between MTR A2756G and MTRR A66G polymorphisms and maternal risk for neural tube defects: A meta-analysis. Gene 515:308-12
98. Ouyang S, Liu Z, Li Y, Ma F, Wu J. 2014. Cystathionine beta-synthase 844ins68 polymorphism is unrelated to susceptibility to neural tube defects. Gene 535:119-23
99. Ouyang S, Liu Z, Li Y, Wu J. 2013. Meta-analyses on the association of MTR A2756G and MTRR A66G polymorphisms with neural tube defect risks in Caucasian children. J. Matern.-Fetal Neonatal Med. 26:1166-70
100. Pangilinan F, Mitchell A, Vander Meer J, Molloy AM, Troendle J, et al. 2010. Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects. J. Med. Genet. 47:677-85
101. Pangilinan F, Molloy AM, Mills JL, Troendle JF, Parle-Mc Dermott A, et al. 2012. Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects. BMC Med. Genet. 13:62
102. Parle-Mc Dermott A, Kirke PN, Mills JL, Molloy AM, Cox C, et al. 2006. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur. J. Hum. Genet. 14:768-72
103. Piao W, Guo J, Bao Y, Wang F, Zhang T, et al. 2016. Analysis of polymorphisms of genes associated with folate-mediated one-carbon metabolism and neural tube defects in Chinese Han population. Birth Defects Res. A Clin. Mol. Teratol. 106:232-39
104. Piedrahita JA, Oetama B, Bennett GD, van Waes J, Kamen BA, et al. 1999. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat. Genet. 23:228-32
105. Pike ST, Rajendra R, Artzt K, Appling DR. 2010. Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos. J. Biol. Chem. 285:4612-20
106. Prasad RB, Groop L. 2015. Genetics of type 2 diabetes: Pitfalls and possibilities. Genes 6:87-123
107. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. 2007. PLINK: A tool set for wholegenome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559-75
108. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, et al. 2007. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 18:362-66
109. Rochtus A, Izzi B, Vangeel E, Louwette S, Wittevrongel C, et al. 2015. DNA methylation analysis of Homeobox genes implicates HOXB7 hypomethylation as risk factor for neural tube defects. Epigenetics 10:92-101
110. Rochtus A, Winand R, Laenen G, Vangeel E, Izzi B, et al. 2016. Methylome analysis for spina bifida shows SOX18 hypomethylation as a risk factor with evidence for a complex (epi)genetic interplay to affect neural tube development. Clin. Epigenet. 8:108
111. Ruggiero JE, Northrup H, Au KS. 2015. Association of facilitated glucose transporter 2 gene variants with the myelomeningocele phenotype. Birth Defects Res. A Clin. Mol. Teratol. 103:479-87
112. Sadewa AH, Sutomo R, Istiadjid M, Nishiyama K, Shirakawa T, et al. 2004. C677T mutation in the MTHFR gene was not found in patients with frontoethmoidal encephalocele in East Java, Indonesia. Pediatr. Int. 46:409-14
113. Schorah CJ, Smithells RW, Scott J. 1980. Vitamin B12 and anencephaly. Lancet 1:880
114. Shah RH, Northrup H, Hixson JE, Morrison AC, Au KS. 2016. Genetic association of the glycine cleavage system genes and myelomeningocele. Birth Defects Res. A Clin. Mol. Teratol. 106:847-53
115. Shaw GM, Lu W, Zhu H, Yang W, Briggs FB, et al. 2009. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med. Genet. 10:49
116. Smith ZD, Meissner A. 2013. DNA methylation: Roles in mammalian development. Nat. Rev. Genet. 14:204-20
117. Smithells RW, Sheppard S. 1980. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1:647
118. Smithells RW, Sheppard S, Schorah CJ. 1976. Vitamin deficiencies and neural tube defects. Arch. Dis. Child. 51:944-50
119. Smithells RW, Sheppard S, Wild J, Schorah CJ. 1989. Prevention of neural tube defect recurrences in Yorkshire: Final report. Lancet 2:498-99
120. Spiegelstein O, Mitchell LE, Merriweather MY, Wicker NJ, Zhang Q, et al. 2004. Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev. Dyn. 231:221-31
121. Spielman RS, Mc Ginnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:506-16
122. Stern LL, Mason JB, Selhub J, Choi SW. 2000. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomark. Prev. 9:849-53
123. Stover PJ, Field MS. 2011. Trafficking of intracellular folates. Adv. Nutr. 2:325-31
124. Suarez L, Hendricks K, Felkner M, Gunter E. 2003. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann. Epidemiol. 13:81-88
125. Sudiwala S, De Castro SC, Leung KY, Brosnan JT, Brosnan ME, et al. 2016. Formate supplementation enhances folate-dependent nucleotide biosynthesis and prevents spina bifida in a mouse model of folic acid-resistant neural tube defects. Biochimie 126:63-70
126. Susser M, Stein Z. 1994. Timing in prenatal nutrition: A reprise of the Dutch Famine Study. Nutr. Rev. 52:84-94
127. Swanson DA, Liu ML, Baker PJ, Garrett L, Stitzel M, et al. 2001. Targeted disruption of the methionine synthase gene in mice. Mol. Cell Biol. 21:1058-65
128. Tibbetts AS, Appling DR. 2010. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30:57-81
129. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-71
130. Wald NJ, Hackshaw AD, Stone R, Sourial NA. 1996. Blood folic acid and vitamin B12 in relation to neural tube defects. Br. J. Obstet. Gynaecol. 103:319-24
131. Wang F, Wang J, Guo J, Chen X, Guan Z, et al. 2013. PCMT1 gene polymorphisms, maternal folate metabolism, and neural tube defects: A case-control study in a population with relatively low folate intake. Genes Nutr. 8:581-87
132. Wang L, Shangguan S, Chang S, Yu X, Wang Z, et al. 2016. Determining the association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and genomic DNA methylation level: A meta-analysis. Birth Defects Res. A Clin. Mol. Teratol. 106:667-74
133. Wang Y, Liu Y, Ji W, Qin H, Wu H, et al. 2015. Analysis of MTR and MTRR polymorphisms for neural tube defects risk association. Medicine 94:e1367
134. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, et al. 1995. Mice deficient in cystathionine beta-synthase: Animal models for mild and severe homocyst(e)inemia. PNAS 92:1585-89
135. Welter D, Mac Arthur J, Morales J, Burdett T, Hall P, et al. 2014. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42:D1001-6
136. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, et al. 1995. A genetic defect in 5, 10 methylenetetrahydrofolate reductase in neural tube defects. Q. J. Med. 88:763-66
137. Wilde JJ, Petersen JR, Niswander L. 2014. Genetic, epigenetic, and environmental contributions to neural tube closure. Annu. Rev. Genet. 48:583-611
138. Witte JS, Visscher PM, Wray NR. 2014. The contribution of genetic variants to disease depends on the ruler. Nat. Rev. Genet. 15:765-76
139. Wlodarczyk BJ, Tang LS, Triplett A, Aleman F, Finnell RH. 2006. Spontaneous neural tube defects in splotch mice supplemented with selected micronutrients. Toxicol. Appl. Pharmacol. 213:55-63
140. Wright AJ, Finglas PM, Dainty JR, Wolfe CA, Hart DJ, et al. 2005. Differential kinetic behavior and distribution for pteroylglutamic acid and reduced folates: A revised hypothesis of the primary site of Pte Glu metabolism in humans. J. Nutr. 135:619-23
141. Wu J, Bao Y, Lu X, Wu L, Zhang T, et al. 2015. Polymorphisms in MTHFD1 gene and susceptibility to neural tube defects: A case-control study in a Chinese Han population with relatively low folate levels. Med. Sci. Monit. 21:2630-37
142. Wu L, Lu X, Guo J, Zhang T, Wang F, Bao Y. 2016. Association between ALDH1L1 gene polymorphism and neural tube defects in the Chinese Han population. Neurol. Sci. 37:1049-54
143. Yadav U, Kumar P, Yadav SK, Mishra OP, Rai V. 2015. Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: An updated meta-analysis. Metab. Brain Dis. 30:7-24
144. Yan L, Zhao L, Long Y, Zou P, Ji G, et al. 2012. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offspring: Evidence from 25 case-control studies. PLOS ONE 7:e41689
145. Yang M, Yang L, Qi L, Guo Y, Lin X, et al. 2013. Association between themethionine synthase A2756G polymorphism and neural tube defect risk: A meta-analysis. Gene 520:7-13
146. Yang Y, Chen J, Wang B, Ding C, Liu H. 2015. Association between MTHFR C677T polymorphism and neural tube defect risks: A comprehensive evaluation in three groups of NTD patients, mothers, and fathers. Birth Defects Res. A Clin. Mol. Teratol. 103:488-500
147. Yates JR, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, Clark BJ. 1987. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects Clin. Genet. 31:279-87
148. Yu Y, Wang F, Bao Y, Lu X, Quan L, Lu P. 2014. Association between MTHFR gene polymorphism and NTDs in Chinese Han population. Int. J. Clin. Exp. Med. 7:2901-6
149. Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, et al. 2016. Describing the prevalence of neural tube defects worldwide: A systematic literature review. PLOS ONE 11:e0151586
150. Zhang T, Lou J, Zhong R, Wu J, Zou L, et al. 2013. Genetic variants in the folate pathway and the risk of neural tube defects: A meta-analysis of the published literature. PLOS ONE 8:e59570
151. Zhang T, Xin R, Gu X, Wang F, Pei L, et al. 2009. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 12:680-86
152. Zhao Q, Behringer RR, de Crombrugghe B. 1996. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nat. Genet. 13:275-83
153. Zollner S, Pritchard JK. 2007. Overcoming the winner's curse: Estimating penetrance parameters from case-control data. Am. J. Hum. Genet. 80:605-15